Endogenous nitric oxide synthase inhibitor as a novel marker of atherosclerosis in humans

被引：0
|
作者：
Miyazaki, H [1 ]
Matsuoka, H [1 ]
Usui, M [1 ]
Ueda, S [1 ]
Okuda, S [1 ]
Imaizumi, T [1 ]
机构：
[1] Kurume Univ, Sch Med, Dept Internal Med 3, Kurume, Fukuoka 830, Japan
来源：
JOURNAL OF HYPERTENSION | 1998年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
P1108
引用
收藏
页码：S87 / S87
页数：1
相关论文
共 50 条
  • [41] Neuronal nitric oxide synthase inhibitor
    不详
    DRUG DISCOVERY TODAY, 1998, 3 (03) : 143 - 143
  • [42] Dysfunction of endothelial nitric oxide synthase and atherosclerosis
    Kawashima, S
    Yokoyama, M
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (06) : 998 - 1005
  • [43] Modulation of the nitric oxide synthase pathway in atherosclerosis
    Maxwell, AJ
    Tsao, PS
    Cooke, JP
    EXPERIMENTAL PHYSIOLOGY, 1998, 83 (05) : 573 - 584
  • [44] Demethylbellidifolin preserves endothelial function by reduction of the endogenous nitric oxide synthase inhibitor level
    Jiang, DJ
    Jiang, JL
    Zhu, HQ
    Tan, GS
    Liu, SQ
    Xu, KP
    Li, YJ
    JOURNAL OF ETHNOPHARMACOLOGY, 2004, 93 (2-3) : 295 - 306
  • [45] Endogenous production of nitric oxide synthase inhibitors
    Anthony, S
    Leiper, J
    Vallance, P
    VASCULAR MEDICINE, 2005, 10 : S3 - S9
  • [46] MOLECULAR MECHANISMS OF ENDOGENOUS NITRIC OXIDE SYNTHASE INHIBITOR ACCUMULATION IN CHRONIC RENAL FAILURE
    Matsuguma, Kyoko
    Ueda, Seiji
    Yamagishi, Sho-Ichi
    Inagaki, Yosuke
    Shibata, Ryo
    Matsumoto, Yuriko
    Kato, Seiya
    Imaizumi, Tsutomu
    Okuda, Seiya
    NEPHROLOGY, 2005, 10 : A249 - A250
  • [47] Probucol preserves endothelial function by reduction of the endogenous nitric oxide synthase inhibitor level
    Jiang, JL
    Li, NS
    Li, YJ
    Deng, HW
    BRITISH JOURNAL OF PHARMACOLOGY, 2002, 135 (05) : 1175 - 1182
  • [48] Effect of simvastatin on endothelium-dependent vasorelaxation and endogenous nitric oxide synthase inhibitor
    Jiang, JL
    Jiang, DJ
    Tang, YH
    Li, NS
    Deng, HW
    Li, YJ
    ACTA PHARMACOLOGICA SINICA, 2004, 25 (07) : 893 - 901
  • [49] Elevated plasma concentrations of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine in citrullinemia
    Luecke, Thomas
    Tsikas, Dimitrios
    Kanzelmeyer, Nele
    Vaske, Bernhard
    Das, Anibh Martin
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2006, 55 (12): : 1599 - 1603
  • [50] Diabetes mellitus increases plasma levels of the endogenous nitric oxide synthase inhibitor.
    Ito, A
    Asagami, T
    Tsao, PS
    Adimoolam, S
    Tsuji, H
    Kimoto, M
    Ogawa, T
    Reaven, GM
    Cooke, JP
    JOURNAL OF INVESTIGATIVE MEDICINE, 1999, 47 (02) : 45A - 45A
12345